[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). Formatting representations of XML (eXtensible Markup Language) elements in this section appear different than shown in Standard ST.26, which may be accessed at: www.wipo.int /export/sites/www/standards/en/pdf/03-26-01.pdf.]

The element InventionTitle described in the table of elements of the general information part (reproduced in MPEP § 2413.01(f) from WIPO Standard ST.26, paragraph 45) as a required element of the "general information" part of the "Sequence Listing XML" must be in the language of filing. It is possible for an applicant to provide more than one InventionTitle element of the general information part in more than one language. However, when the USPTO is the Receiving Office (RO/US) for an international application, the English language is required for the InventionTitle element and also for language-dependent free text of the "Sequence Listing XML." (See MPEP § 2413.01(h) for more information about language-dependent free text.) If non-English language is presented to RO/US for a "Sequence Listing XML," then RO/US will transfer the international application to the International Bureau, under PCT Rule 19.4.